ReNeuron is focused on developing innovative cell-based therapies aimed at addressing significant unmet medical needs. Their technology platform primarily revolves around the use of stem cells, particularly human neural stem cells, which are designed to promote repair and regeneration in damaged tissues. This approach has potential applications in various neurological conditions, including stroke and other central nervous system disorders. ReNeuron's commitment to advancing these therapies is underscored by their ongoing research and clinical trials, which aim to demonstrate the safety and efficacy of their products.

In addition to their stem cell technology, ReNeuron is also exploring the use of exosomes, which are small extracellular vesicles that can facilitate intercellular communication and transport therapeutic molecules. This innovative approach may enhance the delivery of treatments and improve patient outcomes. By leveraging these advanced technologies, ReNeuron aims to create transformative therapies that can significantly improve the quality of life for patients suffering from debilitating conditions.

United Kingdom

Our focus at ReNeuron is on our CustomEx exosome technology platform, producing exosomes with unique tissue targeting tropisms to deliver a payload of choice to a preferred cell type. Our mission is to partner and develop novel exosome therapeutics for diseases with significant unmet needs.

ReNeuron

Company Details